Abstract:Abstract BACKGROUND Intratumor heterogeneity (ITH) in brain tumors has been suggested to increase tumor adaptability and thus drive tumor progression and treatment resistance. Single cell sequencing has widened the range of possibilities in detecting clonal diversity and tumor evolution. As of now, most single cell experiments rely on next-generation sequencing (NGS) platforms. However, they detect only short RNA/DNA fragments that do not show the full picture of existing transcript isoforms or genetic variants. New, long-read sequencing methods such as Oxford Nanopore Technologies (ONT) or PacBio sequencing may now enable novel approaches to single cell experiments. We here set-out to complement existing single-cell analysis workflows and data pipelines with long-read sequencing approaches. We compare and integrate the data output in order to advance the understanding of ITH in brain tumors, paradigmatically demonstrated on meningioma. MATERIAL AND METHODS We set up a pipeline for single-cell/nuclei RNA long-read sequencing on ONT devices. First, libraries as derived from the 10x genomics workflow were employed, subsequently followed by independently generated libraries. To widen the insight into ITH on multiple levels, we next assessed single-cell/nuclei DNA for small somatic variants and methylation along a modified version of this platform. RESULTS Long-read RNA-sequencing yielded results comparable to short-read sequencing. Depending on sample quality, higher reads per cell and library were required for ONT sequencing to achieve similar discrimination of clusters by expression. On the other hand, cell-type specific isoforms could be identified. Specific small somatic variants known from bulk sequencing data were identified when the region was sufficiently covered in the RNA data, which was naturally more often achieved in long read than short-read data. Thus, cell-specific variant calling was enabled in a high-throughput pipeline. Maintaining the methylation information in DNA sequencing could so far only be set-up in a plate-based approach. CONCLUSION Using these approaches, we resolved features of ITH and clonal tumor evolution, aiding us in gaining a broader understanding of brain tumor biology. Furthermore, it showed novel approaches that could possibly be implemented in routine diagnostic procedures in the future. These novel techniques could be applied to other tumor entities and possibly further omics layers such as single cell proteomics and metabolomics could be added to gain a greater understanding of different tumor types and their clonal diversity.

Application of third-generation sequencing in cancer research

Application of long-read sequencing in oncology: progress and challenges

RNA sequencing: new technologies and applications in cancer research

Applications of Nanopore sequencing in precision cancer medicine

The Application of Long-Read Sequencing to Cancer

Advances in Nanopore and Photoelectron-Based High-Throughput Sequencing Technology for Single-Molecule Sequencing

Applications and Potentials of Nanopore Sequencing in the (epi)genome and (epi)transcriptome Era

Single-Cell RNA Sequencing: Technological Progress and Biomedical Application in Cancer Research

Applications of single-cell sequencing in cancer research: progress and perspectives

New-generation high-throughput technologies based 'omics' research strategy in human disease]

[Research Progress and Application of Nanopore Sequencing Technology].

Single-cell RNA Sequencing in Cancer: Applications, Advances, and Emerging Challenges

Prudent Application of Single-Cell RNA Sequencing in Understanding Cellular Features and Functional Phenotypes in Cancer Studies

Abstract 6218: Haplotype-resolved analysis of cancer genomes and epigenomes using Oxford Nanopore sequencing

Cancer liquid biopsies by Oxford Nanopore Technologies sequencing of cell-free DNA: from basic research to clinical applications

Advances in single-cell RNA sequencing and its applications in cancer research

Nanopore sequencing technology, bioinformatics and applications

Spatially Resolved Transcriptomics Technology Facilitates Cancer Research

High resolution copy number inference in cancer using short-molecule nanopore sequencing

P02.13.A THIRD-GENERATION SEQUENCING OF BRAIN TUMORS ON SINGLE-CELL LEVEL

Genomic Sequencing for Cancer Diagnosis and Therapy.